Compare · MDLN vs VAPO
MDLN vs VAPO
Side-by-side comparison of Medline Inc. (MDLN) and Vapotherm Inc. (VAPO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MDLN and VAPO operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN carries a market cap of $53.05B.
- MDLN has hit the wire 10 times in the past 4 weeks while VAPO has been quiet.
- MDLN has more recent analyst coverage (25 ratings vs 2 for VAPO).
- Company
- Medline Inc.
- Vapotherm Inc.
- Price
- -
- -
- Market cap
- $53.05B
- -
- 1M return
- +13.57%
- -
- 1Y return
- -0.90%
- -
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NYSE
- IPO
- 2025
- 2018
- News (4w)
- 10
- 0
- Recent ratings
- 25
- 2
Vapotherm Inc.
Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally. The company offers precision flow systems, such as Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox that deliver heated, humidified, and oxygenated air at a high velocity to patients through a small-bore nasal interface. It also provides companion products, including Vapotherm Transfer Unit, which allows patients to be transferred between care areas within the hospital or ambulate while on therapy; Q50 compressor, which provides compressed air necessary to run the precision flow systems; aerosol aeroneb adaptor to facilitate delivery of ultrasonic aerosolized medication; aerosol disposable patient circuit that is designed to streamline the provision of intermittent and continuous aerosol nebulization by limiting condensate management; and tracheostomy adaptors. In addition, Vapotherm, Inc. offers ProSoft cannula to provide gentle contact with the skin; and disposable products comprising single-use disposables and nasal interfaces, as well as Oxygen Assist Modules, which helps clinicians maintain oxygen levels within a target range. The company sells its products to hospitals. Vapotherm, Inc. was founded in 1993 and is based in Exeter, New Hampshire.
Latest MDLN
- SEC Form 10-Q filed by Medline Inc.
- Medline Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Medline Reports Third Quarter and Nine Months 2026 Results
- Medline announces participation in the 2026 Jefferies Global Healthcare Conference
- Amendment: SEC Form SCHEDULE 13G/A filed by Medline Inc.
- SEC Form 8-K filed by Medline Inc.
- SEC Form 8-K filed by Medline Inc.
- Medline to build Midwestern network with new 800,000-square-foot facility in Van Buren Township, Mich.
- Large owner Gic Private Ltd sold $274,767,093 worth of shares (7,816,987 units at $35.15) (SEC Form 4)
- Medline launches enhanced TrackPoint™ to simplify inventory management for post-acute care
Latest VAPO
- CVRx Appoints John Landry as Chief Financial Officer
- SEC Form 15-12G filed by Vapotherm Inc.
- SEC Form EFFECT filed by Vapotherm Inc.
- SEC Form EFFECT filed by Vapotherm Inc.
- SEC Form EFFECT filed by Vapotherm Inc.
- Amendment: SEC Form SC 13D/A filed by Vapotherm Inc.
- Director Arnerich Anthony L. returned $344,305 worth of shares to the company (232,993 units at $1.48), closing all direct ownership in the company (SEC Form 4)
- President and CEO Army Joseph returned $43,419 worth of shares to the company (452,698 units at $0.10), closing all direct ownership in the company (SEC Form 4)
- SVP & Chief Financial Officer Landry John returned $51,982 worth of shares to the company (71,661 units at $0.73), closing all direct ownership in the company (SEC Form 4)
- SVP & Chief Technology Officer Lawrence Brian returned $81,355 worth of shares to the company (60,188 units at $1.35), closing all direct ownership in the company (SEC Form 4)